These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
145 related articles for article (PubMed ID: 8280698)
41. Malignant melanoma of conjunctiva. Mathur GB; Kothari RS; Mangal HN; Charan H Indian J Ophthalmol; 1971 Mar; 19(1):34-7. PubMed ID: 15744963 [No Abstract] [Full Text] [Related]
42. Conjunctival melanoma arising from primary acquired melanosis in a patient with neurofibromatosis type I. Stacy RC; Kenyon KR; Jakobiec FA; Colby KA Cornea; 2010 Feb; 29(2):232-4. PubMed ID: 20023582 [TBL] [Abstract][Full Text] [Related]
44. Desmoplastic melanoma of the eyelid and conjunctival melanoma in neurofibromatosis type 1: a clinical pathological correlation. Rubinstein TJ; Plesec TP; Singh AD Surv Ophthalmol; 2015; 60(1):72-7. PubMed ID: 25233828 [TBL] [Abstract][Full Text] [Related]
46. [Malignant melanoma of the conjunctiva--clinical course and histopathologic findings]. Stefani FH Fortschr Ophthalmol; 1986; 83(1):141-5. PubMed ID: 3710347 [No Abstract] [Full Text] [Related]
47. Conjunctival melanoma. McGhee CN; Ni C; Albert DM; Chu FR Int Ophthalmol Clin; 1982; 22(3):35-56. PubMed ID: 7107132 [No Abstract] [Full Text] [Related]
48. Malignant melanoma of conjunctiva following surgical excision of naevus. Betharia SM; Vashisht S; Kalra BR Indian J Ophthalmol; 1985; 33(4):259-61. PubMed ID: 3842836 [No Abstract] [Full Text] [Related]
49. Conjunctival metastasis from a cutaneous melanoma as the initial sign of dissemination. Kwapiszeski BR; Savitt ML Am J Ophthalmol; 1997 Feb; 123(2):266-8. PubMed ID: 9186141 [TBL] [Abstract][Full Text] [Related]
53. Use of combination therapy of topical mitomycin C and cyclosporine a as an adjunct to surgery for corneal and conjunctival intraepithelial neoplasia and invasive squamous cell carcinoma. Sugandhi P; George RE Cornea; 2011 Apr; 30(4):486; author reply 486-7. PubMed ID: 21107255 [No Abstract] [Full Text] [Related]
54. Conjunctival Melanoma Responsive to Combined Systemic BRAF/MEK Inhibitors. Dagi Glass LR; Lawrence DP; Jakobiec FA; Freitag SK Ophthalmic Plast Reconstr Surg; 2017; 33(5):e114-e116. PubMed ID: 27893585 [TBL] [Abstract][Full Text] [Related]